The core activity of Gimmune GmbH is the development and production of innovative medical products, particularly: Anti-cancer and anti-viral compounds, Anti-glycan antibodies, Nano-devices for single-cell analysis, Monoclonal antibodies, especially Anti-glyconectin antibodies. The company focuses on research and development (R&D) in the fields of oncology and virology and offers products and services in these areas.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered3
Anti-cancer and anti-viral compounds
Novel anti-cancer and anti-viral compounds for pharmaceutical research and custom-tailored product development.
Anti-glycan antibodies
Anti-glycan antibodies, including anti-glyconectin monoclonal antibodies and monoclonal antibodies against carcino-embryonal markers.
Nano-devices and nano-electrophoresis arrays
Nano-devices, including nano-electrophoresis and nano in micro arrays for single-cell analysis.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.